Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2025-12-24 @ 7:56 PM
NCT ID:
NCT00977704
Brief Summary:
This is an open-label study to assess safety using Restylane and Perlane in the correction of facial wrinkles.
Study:
NCT00977704
Study Brief:
Protocol Section:
NCT00977704